Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Conflict of Interest Disclosures: Dr Odisho reported personal fees from VSee, LLC outside the submitted work. Dr Hong reported a